Trial
NCT05579769
Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
St. Jude Children's Research Hospital
Collaborators
—
Condition
Hematologic Malignancy
Intervention
Ruxolitinib
Why stopped
Principal Investigator left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-02